Join Christina Bevilacqua for the Large Molecule Outsourced Pharma Capabilities Update
In her presentation, Christina will highlight Resilience’s key capabilities and what we deliver in today’s CDMO landscape, including:
-
Digital, real-time quality management systems designed for transparency and control
-
Over 140M units of injectable product delivered to market since 2024
-
Right-first-time performance at scale
